Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

101.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 121.00
  • 52 Week Low: 74.50
  • Currency: UK Pounds
  • Shares Issued: 84.47m
  • Volume: 21,849
  • Market Cap: £85.32m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
54.89% below the market average54.89% below the market average54.89% below the market average54.89% below the market average54.89% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
1yr Revenue Growth
28.85% below the market average28.85% below the market average28.85% below the market average28.85% below the market average28.85% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
26.89% above the market average26.89% above the market average26.89% above the market average26.89% above the market average26.89% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Price Book Ratio
44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
41.74% below the market average41.74% below the market average41.74% below the market average41.74% below the market average41.74% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average
Price Chg 3m
90.51% above the market average90.51% above the market average90.51% above the market average90.51% above the market average90.51% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
62.8% below the market average62.8% below the market average62.8% below the market average62.8% below the market average62.8% below the market average
57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average
Momentum 20
41.59% below the market average41.59% below the market average41.59% below the market average41.59% below the market average41.59% below the market average
63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
19.11% below the market average19.11% below the market average19.11% below the market average19.11% below the market average19.11% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average
ROCE
77.89% below the market average77.89% below the market average77.89% below the market average77.89% below the market average77.89% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
15.65% below the market average15.65% below the market average15.65% below the market average15.65% below the market average15.65% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
29.36% below the market average29.36% below the market average29.36% below the market average29.36% below the market average29.36% below the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average
Operating Profit Loss
12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average12.31% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
0.79% above the market average0.79% above the market average0.79% above the market average0.79% above the market average0.79% above the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average
Cash
20.26% above the market average20.26% above the market average20.26% above the market average20.26% above the market average20.26% above the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
0.75% below the market average0.75% below the market average0.75% below the market average0.75% below the market average0.75% below the market average
7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 101.00p
Change Today -2.50p
% Change -2.42 %
52 Week High 121.00
52 Week Low 74.50
Volume 21,849
Shares Issued 84.47m
Market Cap £85.32m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.27% below the market average27.27% below the market average27.27% below the market average27.27% below the market average27.27% below the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average
Price Trend
77.86% above the market average77.86% above the market average77.86% above the market average77.86% above the market average77.86% above the market average
84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average
Income Not Available
Growth
78.59% below the market average78.59% below the market average78.59% below the market average78.59% below the market average78.59% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

Diaceutics Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
10:56 18,143 @ 102.00p
10:43 3,706 @ 102.00p

Diaceutics Key Personnel

CEO Peter Keeling
CFO Nick Roberts

Top of Page